Millions of doses of Johnson & Johnson vaccine are withdrawn from circulation in the United States

Despite this decision, it was allowed to use two batches of this plant.

In a statement released Friday, the FDA did not elaborate on the numbers, although the US press reported that a total of 60 million doses should be dropped, according to The New York Times.

10 million doses will be stored and released.

Johnson & Johnson, in a statement, confirmed the regulatory approval for the use of two batches of vaccine produced at the plant, EFE said.

However, it does not indicate how many doses will have to be destroyed.

“Today’s decision represents a step forward in our ongoing efforts to address this pandemic on a global scale, and we value the close collaboration with the FDA and global health authorities,” said Cathy Vengel, Director of Sales.

In the statement, the FDA also emphasizes that it is currently impossible to authorize production at the Emergent Biosolutions plant in Baltimore, despite working with the company and the pharmacist in this regard.

In April, Johnson & Johnson took over the Emergent BioSolutions factory, where about 15 million doses of a vaccine developed by a North American pharmaceutical company against covid-19 were received, according to figures published by The New York Times. damaged during production.

Two approved lots have been allocated for emergency use in the United States or countries to which the country is exporting.

These vaccines also have a longer shelf life after the FDA confirmed today after Johnson & Johnson announced Thursday it would extend the vaccine’s shelf life by another six weeks.

According to the French agency AFP, the pandemic has killed at least 3,775,362 people worldwide as a result of more than 174.7 million infections.

Read also: US has 445 deaths and 11,611 cases in the last 24 hours